BYUNG GEUN KIM: Open Payments
NPI 1114326758 · GLENDALE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$471 in 32 payments from 10 companies in 2025. Trend: 2023 $922 · 2024 $803 · 2025 $471
Food & beverage: $471
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 14 | $123 |
| GlaxoSmithKline, LLC. | 6 | $111 |
| Ardelyx, Inc. | 2 | $48 |
| Viatris Specialty LLC | 2 | $46 |
| Aimmune Therapeutics, Inc. | 2 | $41 |
| Paratek Pharmaceuticals, Inc. | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Lilly USA, LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
Products named: VOQUEZNA, NUCALA, IBSRELA, YUPELRI, ZENPEP, NUZYRA, ELIQUIS, JARDIANCE.
Industry payments across WI — which companies pay providers there.
